metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
mML - L2 - all population metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - all population
versus ipilimumab alone
	Ipilimumab (10 mg/kg) vs. ipilimumab alone	1	-529 [-1162; 104] /10000 262/365 vs. 279/362	-130 [-556; 296] /10000 328/365 vs. 330/362	-